Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Biorestorative Therapies Inc (BRTX)

Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data GlobeNewswire - Wed Nov 13, 6:00AM CST

BRTX : 1.4800 (+2.42%)
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Nov 12, 3:05PM CST

BRTX : 1.4800 (+2.42%)
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium GlobeNewswire - Wed Nov 6, 6:00AM CST

BRTX : 1.4800 (+2.42%)
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health GlobeNewswire - Tue Nov 5, 6:10AM CST

BRTX : 1.4800 (+2.42%)
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program GlobeNewswire - Thu Oct 31, 6:00AM CDT

BRTX : 1.4800 (+2.42%)
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events GlobeNewswire - Thu Oct 10, 6:00AM CDT

BRTX : 1.4800 (+2.42%)
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference GlobeNewswire - Thu Oct 3, 3:15PM CDT

BRTX : 1.4800 (+2.42%)
BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event Newsfile - Tue Jan 17, 2023

Melville, New York--(Newsfile Corp. - January 17, 2023) - BioRestorative Therapies (NASDAQ: BRTX) ("BioRestorative", "BRTX" or the "Company"), a clinical stage company focused on stem cell-based therapies,...

BRTX : 1.4800 (+2.42%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 FinancialNewsMedia - Tue Nov 15, 2022

EQNX::TICKER_START (OTCQB:OCEL),(NASDAQ:BRTX),(NASDAQ:MDXG),(NYSE:NNVC),(NASDAQ:VCEL) EQNX::TICKER_END

VCEL : 59.11 (+4.23%)
OCEL : 2.7500 (unch)
BRTX : 1.4800 (+2.42%)
MDXG : 9.20 (-0.22%)
NNVC : 1.3400 (+4.69%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 PR Newswire - Tue Nov 15, 2022

/PRNewswire/ -- Chronic obstructive pulmonary disease is a chronic lung disease that prevents airflow from the lungs. The rising incidence of COPD is one...

OCEL : 2.7500 (unch)
BRTX : 1.4800 (+2.42%)
MDXG : 9.20 (-0.22%)
NNVC : 1.3400 (+4.69%)
VCEL : 59.11 (+4.23%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot